Page last updated: 2024-11-05

troglitazone and Anaplastic Astrocytoma

troglitazone has been researched along with Anaplastic Astrocytoma in 3 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"However, its expression in brain tumors has not been studied."1.31Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines. ( Fujieda, M; Kato, M; Nagaya, T; Saito, K; Seo, H; Yoshida, J, 2002)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kambe, A1
Iguchi, G1
Moon, Y1
Kamitani, H1
Watanabe, T1
Eling, TE1
Wu, L1
Eftekharpour, E1
Davies, GF1
Roesler, WJ1
Juurlink, BH1
Kato, M1
Nagaya, T1
Fujieda, M1
Saito, K1
Yoshida, J1
Seo, H1

Other Studies

3 other studies available for troglitazone and Anaplastic Astrocytoma

ArticleYear
Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents.
    Biochimica et biophysica acta, 2008, Volume: 1783, Issue:6

    Topics: Antineoplastic Agents; Astrocytoma; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases;

2008
Troglitazone selectively inhibits glyoxalase I gene expression.
    Diabetologia, 2001, Volume: 44, Issue:11

    Topics: Animals; Antioxidants; Astrocytoma; Cell Culture Techniques; Cells, Cultured; Chromans; Gene Express

2001
Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines.
    Japanese journal of cancer research : Gann, 2002, Volume: 93, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Astrocytoma; Blotting, Northern; Brain Neoplasms; Cell Division; C

2002